Login/Sign Up
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's belongs to the group of monoclonal antibodies used in the post-exposure treatment of mild to moderate respiratory illness caused by COVID-19 in people aged 12 years or older, weighing at least 40kgs. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is used in non-hospitalised cases of COVID-19 that are at risk of progressing to severe disease.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's contains Casirivimab and Imdevimab which work by using proteins (monoclonal antibodies) that mimic the natural immune system of the body and fight off the harmful virus. They block the virus attachment and entry into the human cells, thereby preventing the progression of the illness.
A qualified healthcare professional will administer Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's. Do not self-administer. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's may cause certain common side effects such as redness, pain and soreness at the injection site. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
It is advisable to inform the doctor if you are allergic to any of its components. Consult your doctor if you are pregnant, planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is not authorized for use in patients who require oxygen therapy or hospitalisation due to COVID-19.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's contains monoclonal antibodies used in the post-exposure treatment of mild to moderate disease caused by SARS-CoV-2. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's works by using monoclonal proteins to imitate the natural defence mechanism of the body. The COVID virus contains a capsid with spike proteins, through which it penetrates into the body cells to cause infection. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's binds to the spike protein of the virus. Thereby blocking the spike protein of the virus from attaching to the human receptor cell and arresting the progress of the disease. Hence, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's finds use in preventing the progression of mild to moderate covid cases to severe cases requiring hospitalisation. Thus, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's finds use in reducing rates of hospitalisation. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's may also be used as post-exposure prophylaxis of coronavirus disease in people who are not fully vaccinated against COVID-19, people with immunocompromising conditions, and in those who are at high risk of being exposed to someone with COVID-19.
It is advisable to inform the doctor if you are allergic to any of its components. Keep your doctor informed if you suffer from any chronic diseasea such as HIV, asthma, cancer, liver disease, kidney problems, heart disease, neurodevelopmental disorders, sickle cell disease or if you have recently had surgery, gastrostomy, tracheostomy or positive pressure ventilation. Offer a detailed medical and vaccination history. Discuss any recent vaccinations with the doctor. Inform the doctor especially if you are on any radiotherapy, immunosuppressant drugs, blood thinners or any other medicines. Consult your doctor if you are planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is not meant for use as vaccination and in severe hospitalised cases.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: No interactions found.
Coronavirus Disease: Coronavirus disease is an infection caused by the SARS-CoV-2 virus. It can range from a mild cold, cough and fever to full-blown pneumonia. Coronavirus belongs to a group of RNA viruses and has crown-like projections on the surface of the pathogen. The virus transmits through droplets generated from an infectious person’s cough, sneeze or heavy breathing. The common symptoms of coronavirus disease are dry cough, tiredness, breathlessness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache, and sore throat.
About Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's belongs to the group of monoclonal antibodies used in the post-exposure treatment of mild to moderate respiratory illness caused by COVID-19 in people aged 12 years or older, weighing at least 40kgs. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is used in non-hospitalised cases of COVID-19 that are at risk of progressing to severe disease.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's contains Casirivimab and Imdevimab which work by using proteins (monoclonal antibodies) that mimic the natural immune system of the body and fight off the harmful virus. They block the virus attachment and entry into the human cells, thereby preventing the progression of the illness.
A qualified healthcare professional will administer Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's. Do not self-administer. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's may cause certain common side effects such as redness, pain and soreness at the injection site. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
It is advisable to inform the doctor if you are allergic to any of its components. Consult your doctor if you are pregnant, planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is not authorized for use in patients who require oxygen therapy or hospitalisation due to COVID-19.
₹97990*
MRP ₹119500
18% off
₹101575*
MRP ₹119500
15% CB
₹17925 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Uses of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's
Medicinal Benefits
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's contains monoclonal antibodies used in the post-exposure treatment of mild to moderate disease caused by SARS-CoV-2. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's works by using monoclonal proteins to imitate the natural defence mechanism of the body. The COVID virus contains a capsid with spike proteins, through which it penetrates into the body cells to cause infection. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's binds to the spike protein of the virus. Thereby blocking the spike protein of the virus from attaching to the human receptor cell and arresting the progress of the disease. Hence, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's finds use in preventing the progression of mild to moderate covid cases to severe cases requiring hospitalisation. Thus, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's finds use in reducing rates of hospitalisation. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's may also be used as post-exposure prophylaxis of coronavirus disease in people who are not fully vaccinated against COVID-19, people with immunocompromising conditions, and in those who are at high risk of being exposed to someone with COVID-19.
Side Effects of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's
Directions for Use
Storage
Drug Warnings
It is advisable to inform the doctor if you are allergic to any of its components. Keep your doctor informed if you suffer from any chronic diseasea such as HIV, asthma, cancer, liver disease, kidney problems, heart disease, neurodevelopmental disorders, sickle cell disease or if you have recently had surgery, gastrostomy, tracheostomy or positive pressure ventilation. Offer a detailed medical and vaccination history. Discuss any recent vaccinations with the doctor. Inform the doctor especially if you are on any radiotherapy, immunosuppressant drugs, blood thinners or any other medicines. Consult your doctor if you are planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection 1's is not meant for use as vaccination and in severe hospitalised cases.
Therapeutic Class
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Coronavirus Disease: Coronavirus disease is an infection caused by the SARS-CoV-2 virus. It can range from a mild cold, cough and fever to full-blown pneumonia. Coronavirus belongs to a group of RNA viruses and has crown-like projections on the surface of the pathogen. The virus transmits through droplets generated from an infectious person’s cough, sneeze or heavy breathing. The common symptoms of coronavirus disease are dry cough, tiredness, breathlessness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache, and sore throat.